It is more imperative than ever to use caution. MDCN Key Indicators to Learn Before Investing


The stock of Medican Enterprises Inc [MDCN] was up 38.46% at its previous close as it traded at $0.0018. In comparison to the 30-day average volume of 1.03B, the volume of the stock reached 1.95B. The stock value of the company has averaged between $0.0001 and $0.0040 over the last 52 weeks.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Medican Enterprises Inc [MDCN] has every intention of fulfilling its obligations of filing and reporting on time. In order to renew the Company’s registration with the Nevada Department of Commerce, two institutional investors contributed funds to its resident agent.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


Read More


February 25, 2021, this corporate update by Medican Enterprises Inc. (OTC Pink: MDCN) serves to apprise all stakeholders of the latest developments.

In July 2019, Medican signed a deal with Immediate Properties LLC in which Ken Williams was required to step down from all positions within three months. Dana Belle was immediately named interim CEO and director.

Investing and developing residential and commercial real estate is the specialty of Immediate Properties. A key aspect of the Company’s success is the strategic relationship the company has built with top equity suppliers, such as individual, commercial and institutional sources. Immediate Properties’ relationships with these banks and institutions have enabled us to do more than find and acquire income-producing properties.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 


A number of technology companies are developing drugs that are likely to cure diseases, making biotech stocks lucrative for investors hoping for a cure.


Please enter your comment!
Please enter your name here